NFKB1 and glioma: Li et al. reported that downregulated CUEDC2 expression in glioma and glioma cell lines led to the promotion of tumorigenicity and proliferation of tumor cells through the activation of STAT3 and nuclear factor kappa B (NF-kB) pathway [18].